Related references
Note: Only part of the references are listed.Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD
Koichi Takahashi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
Qaiser Bashir et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience
S. Le Gouill et al.
ANNALS OF ONCOLOGY (2012)
TRANSPLANTATION Azacitidine after allo-SCT: the good without the bad?
Mohamad Mohty et al.
BLOOD (2012)
The EBMT activity survey: 1990-2010
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2012)
Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need
Avichai Shimoni et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry
Roel J. W. van Kampen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia
C. Craddock et al.
LEUKEMIA (2011)
Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission
Satoshi Nishiwaki et al.
BLOOD (2010)
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2010)
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Michel Duval et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
M. Mohty et al.
LEUKEMIA (2010)
Allogeneic hematopoietic cell transplantation: the state of the art
Boglarka Gyurkocza et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Allogeneic transplants in follicular lymphoma: Higher risk of disease progression after reduced-intensity compared to myeloablative conditioning
Parameswaran Hari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy
T. H. Terwey et al.
BONE MARROW TRANSPLANTATION (2008)
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty et al.
HAEMATOLOGICA (2008)
Fludarabine-meiphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated MD Anderson Cancer Center experience
Paolo Anderlini et al.
HAEMATOLOGICA (2008)
Long-Term Disease-Free Survival After Gemtuzumab, Intermediate-Dose Cytarabine, and Mitoxantrone in Patients With CD33+ Primary Resistant or Relapsed Acute Myeloid Leukemia
Patrice Chevallier et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease
M Yanada et al.
BONE MARROW TRANSPLANTATION (2005)
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
H Bertz et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
